Wednesday, March 29, 2006

Health Canada Issues Tequin Antibiotic Warning

Health Canada Issues Tequin Antibiotic Warning for Diabetics: "The antibiotic Tequin can have life-threatening side-effects in people with diabetes, a study by Canadian researchers has found. The antibiotic gatifloxacin is sold under the brand name Tequin by its manufacturer, Bristol-Myers Squibb. Health Canada is urging doctors to stop prescribing the antibiotic for patients with diabetes as a precaution." [CBC News]